Cases & Deals

Scynexis launches public offering of Common Stock

Clients Scynexis, Inc.

Jones Day led a team that handled the IP diligence for a follow-on public offering of common stock for Scynexis, Inc., a Research Triangle Park, North Carolina, pharmaceutical company committed to the discovery, development, and commercialization of novel anti-infectives. The public offering resulted in the selling of approximately 5.4M shares of common stock at a public offering price of $7.70 per share, providing net proceeds of approximately $37.8M.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.